Kingsview Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16M	Buy	+295,265	New	+$16.5M	0.22%	86
2025 Q3	–	Sell	-237,014	Closed	-$9.62M	–	1306
2025 Q2	$9.62M	Sell	237,014 -23,629	-9%	-$950K	0.16%	117
2025 Q1	$11.4M	Sell	260,643 -4,245	-2%	-$187K	0.22%	92
2024 Q4	$11.4M	Buy	+264,888	New	+$12M	0.22%	85
2024 Q3	–	Sell	-148,890	Closed	-$5.92M	–	1164
2024 Q2	$5.92M	Buy	148,890 +5,027	+3%	+$204K	0.14%	163
2024 Q1	$6.2M	Buy	143,863 +115,712	+411%	+$4.99M	0.16%	149
2023 Q4	$1.17M	Buy	28,151 +10,630	+61%	+$403K	0.04%	419
2023 Q3	$696K	Buy	+17,521	New	+$741K	0.03%	532
2023 Q2	–	Sell	-7,580	Closed	-$311K	–	986
2023 Q1	$311K	Buy	+7,580	New	+$319K	0.01%	700